• 1
    Akoun GM, Scarna HM, Milleron BJ, Benichou MP, Herman DP. Serum neuron-specific enolase: a marker for disease extent and response for therapy for small cell lung cancer. Chest 1985; 87: 39.
  • 2
    Ebert W, Hug G, Stabrey A, Bülzebruck H. Neuronspezifische Enolase (NSE) als Marker für das kleinzellige Bronchialkarzinom. Tumordiagn Ther 1990; 11: 601.
  • 3
    Debus E, Moll R, Franke WW, Weber K, Osborn M. Immunohis-tochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 1984; 114: 12130.
  • 4
    Sundström BE, Natrath WBJ, Stigbrand T. Diversity in immunoreactivity of tumor derived cytokeratin monoclonal antibodies. Histochem Cytochem 1989; 37: 184854.
  • 5
    Broers JL, Rot MK, Oostendorp T, Huysmans A, Wagenaar SS, Wiersma-van-Tilburg AJ, et al. Immunohistochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal and neuroendocrine antigens. Cancer Res 1987; 47: 322534.
  • 6
    Broers JL, Ramaekers FC, Rot MK, Oostendorp T, Huysmans A, van Muijen GN, et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 1988; 48: 32219.
  • 7
    Bodenmüller H, Banauch D, Ofenloch B, Jaworek D, Dessauer A. Technical evaluation of a new automated tumor marker assay: the Enzymun-Test CYFRA 21-1. In: KlapdorR, editor. Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the 90th. Zuckschwerdt: Verlag, 1992: 1378.
  • 8
    Stieber P, Nagel D, Ritzke Ch, Rössler N, Kirsch CM, Eiérmann W, et al. Significance of bone alkaline phosphatase, CA 15-;3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma. Eur J Clin Chem Clin Biochem 1992; 30: 80914.